Search for: "Mylan Inc."
Results 401 - 420
of 674
Sort by Relevance
|
Sort by Date
7 Oct 2011, 7:00 am
Mylan Labs., Inc., 549 F.3d 1381, 1387–88 (Fed. [read post]
21 Sep 2011, 6:41 am
Mylan Bertek Pharmaceuticals, Inc., Civil No. 09-690 (JNE/JSM), 2010 WL 2519988 (D. [read post]
20 Sep 2011, 2:26 pm
Mylan, Inc., United States District Court, District of Delaware, Civil Action No. 10-1077, August 31, 2011. [read post]
10 Sep 2011, 12:25 am
Mylan Pharma., Inc., C.A. [read post]
8 Sep 2011, 12:59 pm
., a maker and distributor of generic drugs, engaged in an illegal drug- switching scheme to increase sales, the U.S. said in a lawsuit in which two Mylan Inc. units are also accused by a whistleblower of wrongdoing. [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog) Please join the… [read post]
30 Aug 2011, 5:18 am
Mylan Inc., 09-8824, U.S. [read post]
29 Aug 2011, 5:53 am
After the Federal Circuit's decision in Thereasense, Inc. v. [read post]
27 Aug 2011, 7:55 pm
Mylan Labs., Inc., 464 F.3d 1286, 1289 (Fed. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
23 Aug 2011, 7:27 am
Mylan, Inc., 2011 U.S. [read post]
18 Aug 2011, 11:10 pm
The Court is currently in its summer recess. [read post]
10 Aug 2011, 8:59 am
Mylan Pharmaceuticals Inc., C.A. [read post]
9 Aug 2011, 9:50 am
Mylan, Inc., 661 F. [read post]
6 Aug 2011, 2:27 pm
.'s policy with Warren Funeral Chapel Inc. covered emotional distress under its definition of bodily injury. [read post]
6 Aug 2011, 12:18 am
(The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc, Cephalon France SAS and Cephalon (UK) Ltd v Orchid Europe Ltd and Generics (UK) Ltd (t/a Mylan) / ???? [read post]
5 Aug 2011, 12:29 pm
Manufacturers who have filed the appeal are: Actavis, Inc., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc,… [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
27 Jul 2011, 4:06 pm
The court granted leave to file briefs amici curiae to Teva Pharmaceuticals, USA, Inc., Mylan Pharmaceuticals Inc., Apotex Inc. and Impax Laborato- ries, Inc., Consumer Federation of America and National Legislative Association on Prescription Drug Prices, and Generic Pharmaceutical Association.The petition for rehearing was considered by the panel that heard the appeal, and thereafter the petition for rehearing en banc, the response to the petition, and… [read post]
